University of Brescia
Also known as: Alfredo Berruti | A.O. Ospedale Papa Giovanni XXIII | A.O. Papa Giovanni XXIII | A.O. Papa Giovanni XXIII di Bergamo, Oncologia Medica | A.O. Papa Giovanni XXIII di Bergamo USC Ematologia | A.O.U. San Giovanni Battista Molinette | ASST - Papa Giovanni XXIII | ASST Papa Giovanni XXIII | ASST Papa Giovanni XXIII, Bergamo, Italy | ASST Papa Giovanni XXIII, Bergamo, Italy/IRCCS - Mario Negri Institute for Pharmacological Research | ASST Spedali Civili, Brescia | ASST Spedali Civili di Brescia | Azienda Ospedale San Giovanni | Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona | Azienda Ospedaliera Papa Giovanni XXIII | Azienda Ospedaliera Papa Giovanni XXIII, Bergamo | Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy | Azienda Ospedaliera Papa Giovanni XXIII (Former:Ospedali Riuniti di Bergamo) | Azienda Ospedaliera Spedali Civili, Brescia | Azienda Ospedaliera Spedali Civili di Brescia | Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino | Brescia University | Centro Regionale Sclerosi Multipla Piazzale Spitali Civili 1 25123 Brescia | Chair of Haematology, Brescia University | Dipartimento di Medicina Interna, Nefrologia e dialisi - Ospedale San Giovanni Battista - Foligno (Perugia) Italy | Division of Hematology, A.O.U. San Giovanni Battista | Gono - ASST Spedali Civili Brescia | Gruppo Ospedaliero San Donato, Bergamo | Gruppo Ospedaliero San Donato, Policlinico San Pietro, Ponte San Pietro, Bergamo | Hematology Division. Ospedale San Giovanni Battista. Torino | IOSI, Ospedale San Giovanni | IOSI - Ospedale San Giovanni, Bellinzona | IOSI -Ospedale San Giovanni, Bellinzona | IOSI, Ospedale San Giovanni Bellinzona | Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni | Istituto Oncologico della Svizzera Italiana- Ospedale s.Giovanni - 6500 Bellinzona, Switzerland | Ospedale di Brescia | Ospedale San Giovanni | Ospedale San Giovanni di Roma | Ospedale SS Giovanni e Paolo - Venezia, Italy | Papa Giovanni XXIII Hospital | Papa Giovanni XXIII Hospital Bergamo | Radiotherapy Dept., Brescia Hospital and Brescia University | SCDO Ematologia 2 AOU San Giovanni Battista Torino | SCDO Ematologia AOU San Giovanni Battista Torino | S.C. Ematologia 2 ASO San Giovanni Battista Torino | S.C. Ematologia II - OSP.S. GIOV.BATTISTA MOLINETTE - TORINO (TO) - | Strutture Ospedaliere - Cliniche San Pietro - AOU Sassari | Università degli Studi di Brescia | Università degli Studi di Brescia ASST degli Spedali Civili di Brescia | University of Brescia (Italy) | University of Brescia, Italy | University of Brescia, Unit of Gastroenterology | USC Ematologia, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
Highest phase reached
Phase 4
First clinical trial
Feb 1, 1994Last known activity
Aug 11, 2025
Timeline
1980s
- Jan 1, 1982
University of Brescia— Founded
Drugs by trial phase (159 distinct, 113 trials)
Phase 4 (31 own, 0 via acquisition)
Phase 3 (55 own, 0 via acquisition)
Phase 2 (51 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (17 own, 0 via acquisition)
Indications
Studied for
- Acute Disease
- Adrenocortical Carcinoma
- Appendicitis
- Asthma
- Atrial Fibrillation
- Brain Diseases
- Breast Neoplasms
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Celiac Disease
- Central Nervous System Neoplasms
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Crohn Disease
- Cushing Syndrome
- Diabetic Nephropathies
- Essential Hypertension
- Glaucoma
- Glaucoma, Open-Angle
- Glioblastoma
- Glomerulonephritis
- Glomerulonephritis, Membranous
- Graft vs Host Disease
- Head and Neck Neoplasms
- Heart Failure
- Hematologic Neoplasms
- Hepatic Encephalopathy
- Hydrophthalmos
- Hypertension
- Hypertrophy
- Hypertrophy, Left Ventricular
- Hyponatremia
- Infections
- Inflammation
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Kidney Diseases
- Kidney Failure, Chronic
- Laryngeal Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoproliferative Disorders
- Macular Degeneration
- Macular Edema
- Mouth Neoplasms
- Multiple Myeloma
- Multiple Sclerosis
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Nasopharyngeal Carcinoma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Nervous System Neoplasms
- Ocular Hypertension
- Ovarian Cysts
- Ovarian Neoplasms
- Peritonitis
- Pharyngeal Neoplasms
- Polycythemia
- Polycythemia Vera
- Preleukemia
- Prostatic Neoplasms
- Sclerosis
- Shock
- Shock, Cardiogenic
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Syndrome
- Triple Negative Breast Neoplasms
- Ulcer
- Uremia
- Urinary Bladder Neoplasms
- Vaginal Diseases
- Vaginosis, Bacterial
- Wet Macular Degeneration
Recent trials (50)
- NCT07104097Sponsor investigatorN/AAug 11, 2025
- NCT07104097Lead sponsorN/AAug 11, 2025
- NCT07089368Sponsor investigatorN/AJul 31, 2025
- NCT07089368Lead sponsorN/AJul 31, 2025
- NCT06375915CollaboratorPhase 2May 1, 2024
- NCT06163833CollaboratorPhase 2Sep 19, 2023
- NCT06800274Sponsor investigatorPhase 4Apr 21, 2023
- NCT06800274Lead sponsorPhase 4Apr 21, 2023
- NCT07232953OfficialPhase 2Nov 10, 2022
- NCT05290285CollaboratorN/AMay 1, 2022
- NCT05705037Reponsible party - principal investigatorN/AJan 10, 2022
- NCT05705037Lead sponsorN/AJan 10, 2022
- NCT05705037Overall official - principal investigatorN/AJan 10, 2022
- NCT05019846Overall official - principal investigatorPhase 3Sep 30, 2021
- NCT04825990Overall official - principal investigatorPhase 2Jun 12, 2021
Details
- Founded
- Brescia, IT Jan 1, 1982
- Last known activity
- Aug 11, 2025